By gene expression array, RT-PCR, and Western blot, we found that enzalutamide-resistant prostate cancer cells overexpress Tribbles 2 (TRIB2), a member of the Tribbles pseudokinase family (TRIB1-3). The gene discussed is TRIB2; the disease is prostate cancer.